Skip to content

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery

Status
Enrolling by invitation
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06561672
Enrollment
102
Registered
2024-08-20
Start date
2024-09-01
Completion date
2025-06-20
Last updated
2024-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl

Keywords

paracetamol ,tramadol , fentanyl, day case surgeries

Brief summary

Implementation of enhanced recovery in day case surgeries using either preemptive intravenous paracetamol plus tramadol or preemptive intravenous fentanyl.

Detailed description

after being informed about the study and potential risks. All patients giving written consent will be randomized by double blind manner into two equal groups (T group and F group). Using computer generated randomization table; each group consists of 51 patients:Group (T) (n=51): Patients will receive preemptive intravenous infusion of tramadol plus paracetamol . Group (F) (n=51): Patients will receive preemptive intravenous fentanyl.

Interventions

Intravenous infusion of 15mg/kg paracetamol together with 1mg/kg tramadol will be started and to be finished before starting of induction of anesthesia (induction agent will be propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)

DRUGFentanyl

Intravenous injection of 1.5 microgram/kg fentanyl will be given to the patient followed by induction agents (propofol 2mg/kg).

DRUGpropofol and muscle relaxant (cisatracurium)

propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)

DRUGPropofol

propofol 2mg/kg

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for day case surgeries. * Patient acceptance to be included into the study. * Both sex. * Patients with ASA physical status I, II. * BMI 25 - 30 kg m-2. * Duration of surgery from 1-2 hours

Exclusion criteria

-Uncooperative patients and patients with psychological problems.- * Patients with liver or renal impairment. * Patients with history of allergy to drug used in the study. * Patients with chronic pain. * Patient on pain therapy.

Design outcomes

Primary

MeasureTime frameDescription
Enhanced recovery scoreat the end of 24 hour after surgery.A 40-item questionnaire that provides a score (QoR-40) that measure quality of recovery after surgery and anesthesia (enhanced recovery) according to five aspects will be recorded at the end of 24 hours after surgery: Emotional state(n=9) physical comfort(n=12) Psychological support (n=7) physical independence(n=5) pain(n=7) \- Each one of the 40 questions gets a score from one to five at which one is the worst response and five is the best response. When the individual score of all questions are added together we get a total score that ranges from 40 to 200.

Secondary

MeasureTime frameDescription
The duration of PACU stay2 days postoperativetime from patient admission to the PACU till discharge from the PACU
Duration of postoperative hospital stay2 days postoperativetime from patient admission to the PACU till the hospital discharge admission to the PACU till the hospital discharge
Postoperative pain severityrecorded upon arrival to recovery room and at 1, 2, 4, 6 and 12hours postoperatively based(a 10-cm line labeled with worst pain imaginable on the right border and no pain on the left border).
postoperative agitation scoreimmediately after extubation, on arrival to PACU, 10 minutes and 20 minutes after arrival to PACU:Score Term Description * 4 Combative Overtly combative, violent, immediate danger to staff * 3 Very agitated Pulls or removes tubes (s) or catheter(s); aggressive * 2 Agitated Frequent non-purposeful movement * 1 Restless Anxious, but not aggressive or vigorous 0 Alert and calm * 1 Drowsy Not fully alert but has sustained awakening (eye opening or eye contact) to voice (\< 10 seconds) * 2 Light sedation Briefly awaken with eye contact to voice (\> 10 seconds) * 3 Moderate sedation Movement or eye opening to voice (but no eye contact)-4 Deep sedation No response to voice, but movement or eye opening to physical stimulation * 5 Unarousable No response to voice or physical stimulation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026